EMDACEndocrinologic and Metabolic Drugs Advisory Committee (US FDA)
EMDACEast Midlands Dog Agility Club (UK)
EMDACEMS (Emergency Medical Services) Medical Directors Association of California
References in periodicals archive ?
However, the EMDAC voted against (2 to 10) the approval of metreleptin for the treatment of patients with metabolic disorders associated with partial LD.
The EMDAC recommendation was based on data from two pivotal open-label National Institutes of Health (NIH) studies and an additional open-label expanded access study - FHA101.
On October 16, 2013, the Company disclosed that the EMDAC had voted 9 to 2 against approval of Vascepa for the ANCHOR Indication citing, among other things, concerns surrounding the mineral oil placebo and the failure of recent cardiovascular outcome trials to demonstrate meaningful cardiovascular benefit from reduction in triglyceride levels.